Clinical Trial Update: Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled study evaluating three doses of a novel tetracycline for facial acne vulgaris has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Novel tetracycline

Snippet

Sponsor: Almirall, S.A. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08